Irlanda - anglès - HPRA (Health Products Regulatory Authority)

vetpharma animal health, s.l. - enrofloxacin - solution for injection - 100 mg/ml - enrofloxacin - bovine, porcine - antibacterial

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

dopharma research b.v. - enrofloxacin - solution for injection - 100 mg/ml - enrofloxacin - bovine, porcine - antibacterial

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

univet limited - enrofloxacin - powder for use in drinking water - 100 mg/ml - enrofloxacin - fowl - chicken, fowl - turkey - antibacterial

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

univet limited - enrofloxacin - solution for use in drinking water - 100 milligram(s)/millilitre - enrofloxacin - chickens, turkeys - antibacterial

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - enrofloxacin - solution for injection - 100 milligram(s)/millilitre - enrofloxacin

Estats Units - anglès - NLM (National Library of Medicine)

medisca inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) -

Israel - anglès - Ministry of Health

a.l. medi-market ltd. - enrofloxacin - solution for injection - enrofloxacin 50 mg / 1 ml - in calves:treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of pasteurella multocida, mannheimia haemolytica and mycoplasma spp. treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of escherichia coli. treatment of septicaemia caused by enrofloxacin susceptible strains of escherichia coli. treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of mycoplasma bovis.only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

Estats Units - anglès - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy: enrofloxacin 100 injection is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-daytherapy: enrofloxacin 100 injection is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: enrofloxacin 100 injection is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. enrofloxacin 100 injection is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with escherichia coli has been diagnosed.

Portugal - anglès - HMA (Heads of Medicines Agencies)

bayer healthcare - enrofloxacin 100 mg/ml - solution for injection - cattle food, pigs - enrofloxacin

Espanya - anglès - HMA (Heads of Medicines Agencies)

bayer healthcare - enrofloxacin 100 mg/ml - solution for injection - cattle food, pigs - enrofloxacin